表紙
市場調查報告書

動物用醫藥品的全球市場預測:2019-2028年

Global Veterinary Medicines Market Forecast 2019-2028

出版商 Inkwood Research 商品編碼 962720
出版日期 內容資訊 英文 219 Pages
商品交期: 2-3個工作天內
價格
動物用醫藥品的全球市場預測:2019-2028年 Global Veterinary Medicines Market Forecast 2019-2028
出版日期: 2020年10月02日內容資訊: 英文 219 Pages
簡介

全球動物用醫藥品的市場規模,從2019年到2028年的預測期間內,預計為4.53%的年複合成長率。家畜數的增加,醫療費的上升,寵物普及,及疾病盛行率增加,預計影響市場成長。

還有疫苗接種和疾病適時的診斷相關對動物健康的意識高漲,對全球動物用醫藥品的需求劇增有所貢獻。同時,針對動物和人的健康的獸醫用疫苗的副作用,基本的基礎設施的缺乏,高額的疫苗接種,及嚴格的法規,妨礙市場成長。

本報告提供動物用醫藥品的全球市場調查,市場概要,影響市場的因素分析,各市場區隔、子區隔、地區的市場預測,並提供主要企業簡介等資訊。

目錄

第1章 調查範圍、調查手法

  • 調查目的
  • 調查範圍
  • 調查手法
  • 前提條件、限制事項

第2章 摘要整理

  • 市場規模、估計
  • 市場概要

第3章 市場動態

  • 市場定義
  • 主要的促進因素
    • 家畜數的劇增
    • 動物醫療費的上升
    • 所擁有的寵物增加
    • 動物的幾個疾病盛行率的上升
  • 主要的阻礙因素
    • 有關動物用醫藥品的嚴格的法規
    • 對動物用疫苗相關的人及動物健康的副作用
    • 新興經濟各國的畜產基本基礎設施設施的缺乏
    • 疫苗接種的高成本
    • 北美素食主義的人氣高漲

第4章 主要分析

  • 波特的五力分析
  • 價值鏈分析
  • 法律規範
  • COVID-19對動物用醫藥品市場的影響
  • 機會矩陣
  • 業者情勢
  • 主要的投資的考察

第5章 市場:各動物種類

  • 寵物
  • 家畜動物

第6章 市場:各流通管道

  • 零售動物醫藥局
  • 獸醫醫院的藥局

第7章 市場:各給藥途徑

  • 非口服途徑
  • 口服途徑
  • 局部途徑

第8章 市場:各產品

  • 藥物
    • 抗感染疾病
    • 抗發炎藥
    • 寄生蟲驅除劑
  • 疫苗
    • 不活化疫苗
    • 弱毒化疫苗
    • 重組疫苗
  • 藥用飼料添加物
    • 抗生素
    • 氨基酸

第9章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 俄羅斯
    • 波蘭
    • 比利時
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 澳洲、紐西蘭
    • 印度
    • 韓國
    • 泰國
    • 印尼
    • 越南
    • 其他亞太地區
  • 其他地區
    • 南美
    • 中東、非洲

第10章 企業簡介

  • ARCHER DANIELS MIDLAND
  • BIOGENESIS BAGO SA
  • BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • CEVA SANTE ANIMALE
  • DECHRA PHARMACEUTICALS PLC
  • ELANCO
  • EVONIK INDUSTRIES AG (RAG STIFTUNG)
  • HESTER BIOSCIENCES LIMITED
  • INDIAN IMMUNOLOGICALS LIMITED
  • KINDRED BIOSCIENCES
  • MERCK & CO
  • NEOGEN CORPORATION
  • VETOQUINOL (SOPARFIN SCA)
  • VIRBAC SA
  • ZOETIS
目錄
Product Code: 34133

KEY FINDINGS

The global veterinary medicines market is estimated to grow with a CAGR of 4.53% during the forecast period, 2019-2028. The increasing livestock population, rising healthcare expenditure, growing pet ownership, and rising prevalence of diseases, are projected to influence the growth of the market.

MARKET INSIGHTS

Animals undergo different medical conditions that require immediate treatment and attention. Vaccines, medicated feed additives, and drugs, used for such treatment are called veterinary medicines. These prevent or slow the growth of the fungi and bacteria. The company of animals is known to enhance the quality of life, and has a positive impact on human health. There has been a considerable rise in pet ownership across the globe. In 2018 alone, 1 in 80 million households owned a pet in Europe. Thus, such a huge population is fueling the demand for veterinary medicines. Also, the rising awareness of animal health with regard to vaccine regimes and timely diagnosis of diseases are contributing to the surge in demand for veterinary medicines across the world. At the same time, the side effects of veterinary vaccines on animal & human health, lack of basic infrastructure, costly vaccinations, and strict regulations, are set to hamper the market growth.

REGIONAL INSIGHTS

The geographical analysis of the global veterinary medicines market includes the evaluation of Asia Pacific, Europe, North America, and the rest of the world. North America is set to dominate the global market throughout the forecast period. The increasing number of pet owners is one of the dominant factors contributing to the growth of the region.

COMPETITIVE INSIGHTS

The global veterinary medicines market is evaluated to be highly competitive over the forecast period. Some of the major players in the market include, Archer Daniels Midland, Biogenesis Bago SA, Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. SURGING LIVESTOCK POPULATION
    • 3.2.2. INCREASING ANIMAL HEALTHCARE EXPENDITURE
    • 3.2.3. GROWING PET OWNERSHIP
    • 3.2.4. RISE IN THE PREVALENCE OF SEVERAL DISEASES IN ANIMALS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. STRINGENT REGULATIONS WITH RESPECT TO THE VETERINARY MEDICINES
    • 3.3.2. SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
    • 3.3.3. LACK OF BASIC INFRASTRUCTURE FACILITIES FOR THE VETERINARY ANIMALS IN THE UNDERDEVELOPED ECONOMIES
    • 3.3.4. HIGH COST OF VACCINATIONS
    • 3.3.5. RISING POPULARITY OF VEGETARIANISM AND VEGANISM IN NORTH AMERICA

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. VALUE CHAIN ANALYSIS
  • 4.3. REGULATORY FRAMEWORK
  • 4.4. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
  • 4.5. OPPORTUNITY MATRIX
  • 4.6. VENDOR LANDSCAPE
  • 4.7. KEY INVESTMENT INSIGHTS

5. MARKET BY ANIMAL TYPE

  • 5.1. COMPANION ANIMALS
  • 5.2. LIVESTOCK ANIMALS

6. MARKET BY DISTRIBUTION CHANNEL

  • 6.1. RETAIL VETERINARY PHARMACIES
  • 6.2. VETERINARY HOSPITAL PHARMACIES

7. MARKET BY ROUTE OF ADMINISTRATION

  • 7.1. PARENTERAL ROUTE
  • 7.2. ORAL ROUTE
  • 7.3. TOPICAL ROUTE

8. MARKET BY PRODUCT

  • 8.1. DRUGS
    • 8.1.1. ANTI-INFECTIVE
    • 8.1.2. ANTI-INFLAMMATORY
    • 8.1.3. PARASITICIDE
  • 8.2. VACCINES
    • 8.2.1. INACTIVATED VACCINES
    • 8.2.2. ATTENUATED VACCINES
    • 8.2.3. RECOMBINANT VACCINES
  • 8.3. MEDICATED FEED ADDITIVES
    • 8.3.1. ANTIBIOTICS
    • 8.3.2. AMINO ACIDS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. FRANCE
    • 9.2.3. THE UNITED KINGDOM
    • 9.2.4. ITALY
    • 9.2.5. RUSSIA
    • 9.2.6. POLAND
    • 9.2.7. BELGIUM
    • 9.2.8. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. CHINA
    • 9.3.2. JAPAN
    • 9.3.3. AUSTRALIA & NEW ZEALAND
    • 9.3.4. INDIA
    • 9.3.5. SOUTH KOREA
    • 9.3.6. THAILAND
    • 9.3.7. INDONESIA
    • 9.3.8. VIETNAM
    • 9.3.9. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST & AFRICA

10. COMPANY PROFILES

  • 10.1. ARCHER DANIELS MIDLAND
  • 10.2. BIOGENESIS BAGO SA
  • 10.3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
  • 10.4. CEVA SANTE ANIMALE
  • 10.5. DECHRA PHARMACEUTICALS PLC
  • 10.6. ELANCO
  • 10.7. EVONIK INDUSTRIES AG (RAG STIFTUNG)
  • 10.8. HESTER BIOSCIENCES LIMITED
  • 10.9. INDIAN IMMUNOLOGICALS LIMITED
  • 10.10. KINDRED BIOSCIENCES
  • 10.11. MERCK & CO
  • 10.12. NEOGEN CORPORATION
  • 10.13. VETOQUINOL (SOPARFIN SCA)
  • 10.14. VIRBAC SA
  • 10.15. ZOETIS

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - VETERINARY MEDICINES
  • TABLE 2: NUMBER OF HOUSEHOLDS IN THE UNITED STATES OWNING A PET (MILLION)
  • TABLE 3: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 4: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 5: GLOBAL COMPANION ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 6: GLOBAL COMPANION ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 7: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 8: GLOBAL LIVESTOCK ANIMALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 10: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 11: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 12: GLOBAL RETAIL VETERINARY PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 13: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 14: GLOBAL VETERINARY HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 15: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 16: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 17: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: GLOBAL PARENTERAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 19: GLOBAL ORAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 20: GLOBAL ORAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 21: GLOBAL TOPICAL ROUTE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 22: GLOBAL TOPICAL ROUTE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 23: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 24: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 25: GLOBAL DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 26: GLOBAL DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 27: GLOBAL DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 28: GLOBAL DRUGS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 29: GLOBAL VACCINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 30: GLOBAL VACCINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 31: GLOBAL VACCINES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 32: GLOBAL VACCINES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 33: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 34: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 35: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 36: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 37: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 38: GLOBAL VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 39: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 40: NORTH AMERICA VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 41: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 42: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 43: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 44: ASIA PACIFIC VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 45: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 46: REST OF WORLD VETERINARY MEDICINES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: LIVESTOCK SPECIES POPULATION IN INDIA, 2019, (MILLION)
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: GLOBAL VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, IN 2019
  • FIGURE 7: GLOBAL VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, IN 2019
  • FIGURE 10: GLOBAL VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, IN 2019
  • FIGURE 13: GLOBAL VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL VETERINARY MEDICINES MARKET, BY PRODUCT, IN 2019
  • FIGURE 17: GLOBAL VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL DRUGS MARKET, BY ANTI-INFECTIVE, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL DRUGS MARKET, BY ANTI-INFLAMMATORY, 2019-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL DRUGS MARKET, BY PARASITICIDE, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL VACCINES MARKET, BY INACTIVATED VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL VACCINES MARKET, BY ATTENUATED VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL VACCINES MARKET, BY RECOMBINANT VACCINES, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY ANTIBIOTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL MEDICATED FEED ADDITIVES MARKET, BY AMINO ACIDS, 2019-2028 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 29: THE UNITED STATES VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: CANADA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 31: EUROPE VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 32: GERMANY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: FRANCE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: THE UNITED KINGDOM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 35: ITALY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 36: RUSSIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 37: POLAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 38: BELGIUM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 39: REST OF EUROPE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 40: ASIA PACIFIC VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: CHINA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: JAPAN VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: AUSTRALIA & NEW ZEALAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 44: INDIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 45: SOUTH KOREA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: THAILAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 47: INDONESIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 48: VIETNAM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: REST OF ASIA PACIFIC VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: REST OF WORLD VETERINARY MEDICINES MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 51: LATIN AMERICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: MIDDLE EAST & AFRICA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)